{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:27:26Z","timestamp":1778545646038,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.drugalcdep.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T11:01:13Z","timestamp":1474369273000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use"],"prefix":"10.1016","volume":"168","author":[{"given":"M. Eugenia","family":"Soc\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiru","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Shoveller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0005","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S2352-3018(15)00129-0","article-title":"Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study","volume":"2","author":"Ahamad","year":"2015","journal-title":"Lancet HIV"},{"issue":"Suppl. (1)","key":"10.1016\/j.drugalcdep.2016.09.013_bib0010","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12879-015-0913-0","article-title":"Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis","volume":"15","author":"Azar","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e3181900129","article-title":"Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users","volume":"50","author":"Baum","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.lfs.2010.10.002","article-title":"Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV","volume":"88","author":"Carrico","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl J. Med."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.lfs.2011.01.003","article-title":"Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission","volume":"88","author":"Cook","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/oxfordjournals.aje.a008806","article-title":"Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population","volume":"143","author":"De Irala","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1503\/cmaj.082054","article-title":"Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs","volume":"181","author":"DeBeck","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1747-597X-6-4","article-title":"Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder","volume":"6","author":"DeBeck","year":"2011","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/10550887.2013.824328","article-title":"A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence","volume":"32","author":"Farronato","year":"2013","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0060","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1360-0443.2006.01614.x","article-title":"Crack across Canada: comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MEG.0b013e3282f16a8c","article-title":"Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia","volume":"20","author":"Fischer","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10461-012-0319-6","article-title":"Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment","volume":"17","author":"Gonzalez","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial","volume":"14","author":"Grinsztejn","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0080","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","article-title":"Confidence interval estimation of interaction","volume":"3","author":"Hosmer","year":"1992","journal-title":"Epidemiology"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0376-8716(94)01060-X","article-title":"Cocaine use and risky injection and sexual behaviors","volume":"37","author":"Hudgins","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV Infection","volume":"373","author":"Insight Start Study Group","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0095","series-title":"90-90-90 An Ambitious Treatment Target To Help End The AIDS Epidemic","author":"Joint United Nations Programme on HIV\/AIDS","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0000000000000125","article-title":"Challenges in managing HIV in people who use drugs","volume":"28","author":"Kamarulzaman","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/433175","article-title":"The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations","volume":"41","author":"Kapadia","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2011.12.019","article-title":"Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users","volume":"124","author":"Kerr","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ije\/dyr218","article-title":"Recommendations for presenting analyses of effect modification and interaction","volume":"41","author":"Knol","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10654-011-9554-9","article-title":"Estimating measures of interaction on an additive scale for preventive exposures","volume":"26","author":"Knol","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ije\/28.3.514","article-title":"The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities","volume":"28","author":"Langendam","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0130","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/add.12970","article-title":"Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids","volume":"110","author":"Lappalainen","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugalcdep.2008.07.003","article-title":"Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors","volume":"99","author":"Lloyd-Smith","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0140","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.lfs.2010.09.025","article-title":"Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals","volume":"88","author":"Lucas","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0145","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.drugpo.2015.01.015","article-title":"We need somewhere to smoke crack: an ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada","volume":"26","author":"McNeil","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/COH.0b013e328354bcc8","article-title":"Barriers to HIV treatment among people who use injection drugs: implications for \u2018treatment as prevention\u2019","volume":"7","author":"Milloy","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0155","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1007\/s10461-007-9253-4","article-title":"Predicting HIV transmission risk among HIV-infected patients seen in clinical settings","volume":"11","author":"Morin","year":"2007","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0160","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/QAD.0000000000000642","article-title":"The causal effect of opioid substitution treatment on HAART medication refill adherence","volume":"29","author":"Nosyk","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0165","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/cid\/civ476","article-title":"The effects of opioid substitution treatment and highly active antiretroviral therapy on the cause-specific risk of mortality among HIV-positive people who inject drugs","volume":"61","author":"Nosyk","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0170","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy","volume":"84","author":"Palepu","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0175","series-title":"Guidelines For The Use Of Antiretroviral Agents In HIV-1-Infected Adults And Adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0185","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/QAD.0000000000000853","article-title":"Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting","volume":"29","author":"Richardson","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0190","series-title":"21st Conference on Retroviruses and Opportunistic Infections","article-title":"HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. Abstract 153LB","author":"Rodger","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0195","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","volume":"49","author":"Roux","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/B:JOHE.0000016716.99847.9b","article-title":"Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women","volume":"29","author":"Sharpe","year":"2004","journal-title":"J. Community Health"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728214.2015.985203","article-title":"Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy","volume":"20","author":"Shorter","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users","volume":"280","author":"Strathdee","year":"1998","journal-title":"JAMA"},{"issue":"Suppl. (1)","key":"10.1016\/j.drugalcdep.2016.09.013_bib0215","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/QAI.0b013e3182097576","article-title":"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine\/naloxone","volume":"56","author":"Sullivan","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0220","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A Trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Temprano Anrs Study Group Danel","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0225","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0230","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","article-title":"The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence","volume":"81","author":"Williamson","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0235","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.aids.0000168982.20456.eb","article-title":"Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users","volume":"19","author":"Wood","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0240","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jama.300.5.550","article-title":"Highly active antiretroviral therapy and survival in HIV-infected injection drug users","volume":"300","author":"Wood","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0245","series-title":"Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations","first-page":"184","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.09.013_bib0250","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing Hiv Infection: Recommendations for a Public Health Approach","first-page":"78","author":"World Health Organization","year":"2016"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616309115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616309115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T04:31:52Z","timestamp":1536381112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616309115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"alternative-id":["S0376871616309115"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.09.013","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}